| Date | Company Name | Action | Current
Price | Price
Target | Rating | Impact on
Share Price |
|---|
| 2/3/2023 | PHVS Pharvaris | Lower Price Target | $9.00 | $20.00 ➝ $18.00 | Outperform | Low |
| 2/3/2023 | KALV KalVista Pharmaceuticals | Lower Price Target | $8.00 | $30.00 ➝ $20.00 | Outperform | Low |
| 2/3/2023 | MRK Merck & Co., Inc. | Boost Price Target | $103.00 | $120.00 ➝ $122.00 | Outperform | Low |
| 2/3/2023 | IONS Ionis Pharmaceuticals | Boost Price Target | $41.00 | $33.00 ➝ $34.00 | Market Perform | Low |
| 2/3/2023 | BMRN BioMarin Pharmaceutical | Boost Price Target | $112.00 | $122.00 ➝ $130.00 | Outperform | Low |
| 2/3/2023 | TECH Bio-Techne | Lower Price Target | $79.00 | $125.00 ➝ $110.00 | Outperform | Low |
| 2/3/2023 | GILD Gilead Sciences | Boost Price Target | $84.00 | $81.00 ➝ $91.00 | Market Perform | Low |
| 2/2/2023 | AMGN Amgen | Lower Price Target | $245.00 | $282.00 ➝ $267.00 | Market Perform | Low |
| 2/2/2023 | HOLX Hologic | Boost Price Target | $85.00 | $90.00 ➝ $93.00 | Outperform | Low |
| 2/2/2023 | TMO Thermo Fisher Scientific | Boost Price Target | $588.00 | $620.00 ➝ $630.00 | Outperform | Low |
| 2/1/2023 | PFE Pfizer | Lower Price Target | $44.00 | $49.00 ➝ $48.00 | Market Perform | Low |
| 1/30/2023 | DNLI Denali Therapeutics | Reiterated Rating | $32.00 | $50.00 | Outperform | Low |
| 1/27/2023 | CPSI Computer Programs and Systems | Reiterated Rating | $30.00 | | Outperform | Low |
| 1/27/2023 | IQV IQVIA | Reiterated Rating | $237.00 | | Outperform | Low |
| 1/27/2023 | OMCL Omnicell | Reiterated Rating | $57.00 | | Market Perform | Low |
| 1/27/2023 | OPRX OptimizeRx | Reiterated Rating | $19.00 | | Outperform | Low |
| 1/27/2023 | XERS Xeris Biopharma | Lower Price Target | $1.00 | $6.00 ➝ $5.00 | Outperform | Low |
| 1/27/2023 | VIR Vir Biotechnology | Lower Price Target | $30.00 | $45.00 ➝ $43.00 | Outperform | Low |
| 1/27/2023 | SCPH scPharmaceuticals | Boost Price Target | $8.00 | $12.00 ➝ $13.00 | Outperform | Low |
| 1/27/2023 | PRDS Pardes Biosciences | Lower Price Target | $2.00 | $12.00 ➝ $9.00 | Outperform | Low |
| 1/27/2023 | ENTA Enanta Pharmaceuticals | Lower Price Target | $52.00 | $50.00 ➝ $49.00 | Market Perform | Low |
| 1/27/2023 | AVIR Atea Pharmaceuticals | Lower Price Target | $5.00 | $8.00 ➝ $6.00 | Market Perform | Low |
| 1/26/2023 | ELV Elevance Health | Reiterated Rating | $478.00 | $580.00 | Outperform | Low |
| 1/24/2023 | BHVN Biohaven | Reiterated Rating | $18.00 | $24.00 | Outperform | Low |
| 1/24/2023 | PLRX Pliant Therapeutics | Boost Price Target | $33.00 | $33.00 ➝ $45.00 | Outperform | Low |
| 1/23/2023 | RXRX Recursion Pharmaceuticals | Lower Price Target | $10.00 | $9.00 ➝ $8.00 | Market Perform | Low |
| 1/23/2023 | RGNX REGENXBIO | Lower Price Target | $24.00 | $15.00 ➝ $14.00 | Market Perform | Low |
| 1/23/2023 | RCKT Rocket Pharmaceuticals | Lower Price Target | $21.00 | $50.00 ➝ $49.00 | Outperform | Low |
| 1/23/2023 | NTLA Intellia Therapeutics | Lower Price Target | $43.00 | $86.00 ➝ $84.00 | Outperform | Low |
| 1/23/2023 | IONS Ionis Pharmaceuticals | Boost Price Target | $41.00 | $32.00 ➝ $33.00 | Market Perform | Low |
| 1/23/2023 | EDIT Editas Medicine | Boost Price Target | $11.00 | $6.00 ➝ $7.00 | Market Perform | Low |
| 1/23/2023 | DBTX Decibel Therapeutics | Lower Price Target | $3.00 | $10.00 ➝ $7.00 | Outperform | Low |
| 1/23/2023 | BLUE bluebird bio | Lower Price Target | $7.00 | $9.00 ➝ $8.00 | Market Perform | Low |
| 1/23/2023 | BEAM Beam Therapeutics | Lower Price Target | $48.00 | $81.00 ➝ $77.00 | Outperform | Low |
| 1/23/2023 | BBIO BridgeBio Pharma | Lower Price Target | $11.00 | $23.00 ➝ $19.00 | Outperform | Low |
| 1/23/2023 | ALVR AlloVir | Lower Price Target | $6.00 | $25.00 ➝ $19.00 | Outperform | Low |
| 1/23/2023 | ALNY Alnylam Pharmaceuticals | Lower Price Target | $233.00 | $144.00 ➝ $143.00 | Market Perform | Low |
| 1/23/2023 | RLMD Relmada Therapeutics | Lower Price Target | $4.00 | $42.00 ➝ $10.00 | Outperform | Low |
| 1/23/2023 | MRNS Marinus Pharmaceuticals | Lower Price Target | $7.00 | $27.00 ➝ $23.00 | Outperform | Low |
| 1/23/2023 | MRK Merck & Co., Inc. | Boost Price Target | $103.00 | $112.00 ➝ $120.00 | Outperform | Low |
| 1/20/2023 | JNJ Johnson & Johnson | Lower Price Target | $165.00 | $194.00 ➝ $186.00 | Outperform | Low |
| 1/20/2023 | BGNE BeiGene | Boost Price Target | $257.00 | $236.00 ➝ $300.00 | Outperform | Low |
| 1/20/2023 | SGEN Seagen | Boost Price Target | $138.00 | $160.00 ➝ $162.00 | Outperform | Low |
| 1/20/2023 | ZYME Zymeworks | Boost Price Target | $9.00 | $8.00 ➝ $10.00 | Market Perform | Low |
| 1/20/2023 | SRPT Sarepta Therapeutics | Reiterated Rating | $119.00 | $160.00 | Outperform | Low |
| 1/19/2023 | EOLS Evolus | Boost Price Target | $10.00 | $18.00 ➝ $20.00 | Outperform | Low |
| 1/18/2023 | MRNA Moderna | Boost Price Target | $173.00 | $102.00 ➝ $111.00 | Market Perform | Low |
| 1/17/2023 | VRTX Vertex Pharmaceuticals | Upgrade | $301.00 | $374.00 | Market Perform ➝ Outperform | Low |
| 1/12/2023 | HOLX Hologic | Boost Price Target | $85.00 | $85.00 ➝ $90.00 | Outperform | Low |
| 1/12/2023 | EXAS Exact Sciences | Boost Price Target | $67.00 | $70.00 ➝ $75.00 | Outperform | Low |
| 1/11/2023 | HALO Halozyme Therapeutics | Lower Price Target | $53.00 | $62.00 ➝ $61.00 | Outperform | Low |
| 1/10/2023 | OSH Oak Street Health | Boost Price Target | $27.00 | $23.00 ➝ $33.00 | Market Perform | Low |
| 1/10/2023 | TSVT 2seventy bio | Lower Price Target | $14.00 | $41.00 ➝ $34.00 | Outperform | Low |
| 1/10/2023 | KPTI Karyopharm Therapeutics | Lower Price Target | $3.00 | $6.00 ➝ $5.00 | Market Perform | Low |
| 1/10/2023 | EDIT Editas Medicine | Lower Price Target | $11.00 | $7.00 ➝ $6.00 | Market Perform | Low |
| 1/10/2023 | MIRM Mirum Pharmaceuticals | Lower Price Target | $24.00 | $50.00 ➝ $39.00 | Outperform | Low |
| 1/9/2023 | AMYT Amryt Pharma | Downgrade | $15.00 | $19.00 ➝ $14.50 | Outperform ➝ Market Perform | Low |
| 1/9/2023 | VRDN Viridian Therapeutics | Boost Price Target | $37.00 | $40.00 ➝ $45.00 | Outperform | Low |
| 1/6/2023 | GRPH Graphite Bio | Downgrade | $2.00 | $11.00 ➝ $2.00 | Outperform ➝ Market Perform | Low |
| 1/6/2023 | IPSC Century Therapeutics | Lower Price Target | $5.00 | $20.00 ➝ $14.00 | Outperform | Low |
| 1/6/2023 | FATE Fate Therapeutics | Lower Price Target | $7.00 | $62.00 ➝ $10.00 | Outperform | N/A |
| 1/6/2023 | WAT Waters | Boost Price Target | $341.00 | $320.00 ➝ $352.00 | Market Perform | Low |
| 1/6/2023 | TMO Thermo Fisher Scientific | Boost Price Target | $588.00 | $555.00 ➝ $620.00 | Outperform | Low |
| 1/6/2023 | RGEN Repligen | Lower Price Target | $193.00 | $230.00 ➝ $200.00 | Outperform | Low |
| 1/6/2023 | MASS 908 Devices | Lower Price Target | $10.00 | $25.00 ➝ $20.00 | Outperform | Low |
| 1/6/2023 | ABCL AbCellera Biologics | Lower Price Target | $11.00 | $20.00 ➝ $18.00 | Outperform | Low |
| 1/6/2023 | A Agilent Technologies | Boost Price Target | $155.00 | $160.00 ➝ $170.00 | Outperform | Low |
| 1/6/2023 | HOLX Hologic | Boost Price Target | $85.00 | $78.00 ➝ $85.00 | Outperform | Low |
| 1/6/2023 | EXAS Exact Sciences | Boost Price Target | $67.00 | $60.00 ➝ $70.00 | Outperform | Low |
| 1/6/2023 | BLUE bluebird bio | Boost Price Target | $7.00 | $8.00 ➝ $9.00 | Market Perform | Low |
| 1/5/2023 | PHR Phreesia | Boost Price Target | $38.00 | $34.00 ➝ $39.00 | Outperform | Low |
| 1/5/2023 | PGNY Progyny | Reiterated Rating | $36.00 | $59.00 ➝ $34.00 | Outperform ➝ Market Perform | Low |
| 1/5/2023 | COGT Cogent Biosciences | Boost Price Target | $15.00 | $18.00 ➝ $20.00 | Outperform | Low |
| 1/5/2023 | AMED Amedisys | Lower Price Target | $92.00 | $96.00 ➝ $85.00 | Market Perform | Low |
| 1/4/2023 | DCPH Deciphera Pharmaceuticals | Boost Price Target | $17.00 | $25.00 ➝ $28.00 | Outperform | Low |
| 12/27/2022 | AMTI Applied Molecular Transport | Reiterated Rating | $1.00 | | Outperform ➝ Market Perform | Low |
| 12/22/2022 | RCKT Rocket Pharmaceuticals | Lower Price Target | $21.00 | $54.00 ➝ $50.00 | Outperform | Low |
| 12/22/2022 | ISO IsoPlexis | Lower Price Target | $1.00 | $2.50 ➝ $1.50 | Market Perform | Low |
| 12/22/2022 | AMGN Amgen | Boost Price Target | $245.00 | $256.00 ➝ $282.00 | Market Perform | Low |
| 12/20/2022 | NAMS NewAmsterdam Pharma | Initiated Coverage | $13.00 | $19.00 | Outperform | Low |
| 12/20/2022 | MDGL Madrigal Pharmaceuticals | Boost Price Target | $280.00 | $145.00 ➝ $315.00 | Outperform | Low |
| 12/19/2022 | ROIV Roivant Sciences | Boost Price Target | $8.00 | $8.00 ➝ $10.00 | Outperform | Low |
| 12/16/2022 | LLY Eli Lilly and | Boost Price Target | $339.00 | $384.00 ➝ $410.00 | Outperform | Low |
| 12/16/2022 | HCA HCA Healthcare | Boost Price Target | $258.00 | $238.00 ➝ $286.00 | Outperform | Low |
| 12/16/2022 | AXLA Axcella Health | Reiterated Rating | $1.00 | $6.00 ➝ $2.00 | Outperform ➝ Market Perform | Low |
| 12/16/2022 | PCVX Vaxcyte | Reiterated Rating | $45.00 | $60.00 | Outperform | Low |
| 12/15/2022 | KYMR Kymera Therapeutics | Boost Price Target | $37.00 | $26.00 ➝ $31.00 | Market Perform | Low |
| 12/14/2022 | MIRM Mirum Pharmaceuticals | Boost Price Target | $24.00 | $49.00 ➝ $50.00 | Outperform | Low |
| 12/14/2022 | MRTX Mirati Therapeutics | Lower Price Target | $53.00 | $85.00 ➝ $75.00 | Outperform | Low |
| 12/14/2022 | WVE Wave Life Sciences | Boost Price Target | $5.00 | $2.00 ➝ $7.00 | Market Perform | Low |
| 12/13/2022 | FATE Fate Therapeutics | Lower Price Target | $7.00 | $64.00 ➝ $62.00 | Outperform | Low |
| 12/13/2022 | HZNP Horizon Therapeutics Public | Downgrade | $110.00 | $88.00 ➝ $116.50 | Outperform ➝ Market Perform | Low |
| 12/13/2022 | SPRY ARS Pharmaceuticals | Initiated Coverage | $7.00 | $14.00 | Outperform | Low |
| 12/13/2022 | NRIX Nurix Therapeutics | Lower Price Target | $13.00 | $37.00 ➝ $28.00 | Outperform | Low |
| 12/13/2022 | MRNA Moderna | Boost Price Target | $173.00 | $101.00 ➝ $102.00 | Market Perform | Low |
| 12/12/2022 | AFMD Affimed | Lower Price Target | $1.00 | $10.00 ➝ $6.00 | Outperform | Low |
| 12/12/2022 | BGNE BeiGene | Boost Price Target | $257.00 | $210.00 ➝ $236.00 | Outperform | Low |
| 12/9/2022 | PHR Phreesia | Upgrade | $38.00 | $31.00 ➝ $34.00 | Market Perform ➝ Outperform | Low |
| 12/9/2022 | DSGN Design Therapeutics | Lower Price Target | $8.00 | $30.00 ➝ $22.00 | Outperform | Low |
| 12/8/2022 | MRTX Mirati Therapeutics | Lower Price Target | $53.00 | $102.00 ➝ $85.00 | Outperform | Low |
